Viewing Study NCT00257205


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-26 @ 2:01 AM
Study NCT ID: NCT00257205
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 2005-11-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module